Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
1978-12-29
|
| pubmed:commentsCorrections | |
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0306-5251
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
6
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
372-3
|
| pubmed:dateRevised |
2009-11-18
|
| pubmed:meshHeading |
pubmed-meshheading:698033-Administration, Oral,
pubmed-meshheading:698033-Adult,
pubmed-meshheading:698033-Humans,
pubmed-meshheading:698033-Injections, Intravenous,
pubmed-meshheading:698033-Kinetics,
pubmed-meshheading:698033-Male,
pubmed-meshheading:698033-Mexiletine,
pubmed-meshheading:698033-Propylamines,
pubmed-meshheading:698033-Time Factors
|
| pubmed:year |
1978
|
| pubmed:articleTitle |
Mexiletine in normal volunteers.
|
| pubmed:publicationType |
Journal Article
|